Abstract

MINIMIZING RISK OF POSTMENOPAUSAL OSTEOPOROSIS THROUGH SHATAVARI – A CLINICAL STUDY

*Jasmine Ritesh ujarathi¹, Ritesh Ashok Gujarathi²

Abstract

The postmenopausal period is associated with significant increase in the incidence of age related medical conditions like cardiovascular diseases and osteoporosis. Postmenopausal Osteoporosis is a condition of major health importance because of its association with fractures. Bone loss is only partly reversible. Hence treatment is aimed at minimizing the bone loss after the age of 40. Postmenopausal osteoporosis is a disease of ageing. Rasayana can provide better alternative in increasing quality of life. Shatavari (Asparagus racemosus) is a well-known female rejuvenative. Its beneficial effect on women during fertile i.e. reproductive life is well established. In the present clinical study Shatavari was administered in perimenopausal and menopausal women; 6gms / day in two divided doses with milk for 10 weeks. At the end of the study it showed highly significant (P

Keywords: Postmenopausal osteoporosis, Bone loss, Rasayana, Shatavari.